Skip to content

Aktis Oncology, Inc.

AKTS · XNAS

CIK 2035832fmd_1YNH2PXEGZ48G2PDGGMRSYBEAZManufacturing · Pharmaceutical PreparationsTemplate: Standard

Coverage: Jan 01, 2025 to Sep 30, 2026, 6 periods

Loading statement
Aktis Oncology, Inc. (AKTS) financial statements · FinancialMD